Retour
52
39
Également cotée sous
GLPGF
OTC
Fourchette du Jour
29,68 €
31,40 €
Fourchette 52 Semaines
22,59 €
37,78 €
Volume
616 445
Moyenne 50J / 200J
33,57 €
/
32,14 €
Clôture Précédente
31,90 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 6,1 | 0,3 |
| P/B | 0,6 | 2,9 |
| ROE % | 10,5 | 3,7 |
| Net Margin % | 28,9 | 3,8 |
| Rev Growth 5Y % | 23,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
36,50 €
+22.5%
Low: 33,00 €
High: 40,00 €
BPA Prévisionnel
-1,65 €
CA Est.
160 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-1,61 €
-3,22 € – -0,03 €
|
47 M | 1 |
| FY2029 |
-1,60 €
-3,20 € – -0,03 €
|
37 M | 1 |
| FY2028 |
-1,63 €
-3,25 € – -0,03 €
|
100 M | 1 |
Points Clés
Revenue grew 23,07% annually over 5 years — strong growth
Earnings grew 333,17% over the past year
ROE of 10,47% — decent returns on equity
Net margin of 28,85% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -202,40M
Croissance
Revenue Growth (5Y)
23,07%
Revenue (1Y)303,48%
Earnings (1Y)333,17%
FCF Growth (3Y)N/A
Qualité
Return on Equity
10,47%
ROIC10,42%
Net Margin28,85%
Op. Margin40,56%
Sécurité
Debt / Equity
0,00
Current Ratio20,15
Interest Coverage164,04
Valorisation
P/E Ratio
6,12
P/B Ratio0,61
EV/EBITDA4,19
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 303,48% | Revenue Growth (3Y) | 115,40% |
| Earnings Growth (1Y) | 333,17% | Earnings Growth (3Y) | 23,12% |
| Revenue Growth (5Y) | 23,07% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,11B | Net Income (TTM) | 320,90M |
| ROE | 10,47% | ROA | 9,42% |
| Gross Margin | 93,49% | Operating Margin | 40,56% |
| Net Margin | 28,85% | Free Cash Flow (TTM) | -202,40M |
| ROIC | 10,42% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 20,15 |
| Interest Coverage | 164,04 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 6,12 | P/B Ratio | 0,61 |
| P/S Ratio | 1,77 | PEG Ratio | 0,02 |
| EV/EBITDA | 4,19 | Dividend Yield | 0,00% |
| Market Cap | 1,96B | Enterprise Value | 1,89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,11B | 275,65M | 239,72M | 241,25M | 484,85M |
| Net Income | 320,90M | 74,08M | 211,70M | -217,99M | -125,42M |
| EPS (Diluted) | 4,85 | 1,12 | -0,06 | -3,32 | -1,91 |
| Gross Profit | 1,04B | 240,79M | 239,72M | 241,25M | 483,22M |
| Operating Income | 451,12M | -188,34M | -88,26M | -131,06M | -165,60M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,41B | 4,14B | 4,36B | 4,73B | 5,19B |
| Total Liabilities | 170,58M | 1,24B | 1,56B | 2,21B | 2,55B |
| Shareholders' Equity | 3,23B | 2,90B | 2,80B | 2,53B | 2,64B |
| Total Debt | 12,10M | 11,72M | 9,60M | 21,90M | 26,86M |
| Cash & Equivalents | 87,83M | 64,24M | 166,80M | 508,12M | 2,23B |
| Current Assets | 3,08B | 3,34B | 3,86B | 4,24B | 4,86B |
| Current Liabilities | 152,80M | 335,08M | 428,22M | 522,54M | 566,47M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#123 of 709
Custom
Full Throttle
#89 of 146
Activité Récente
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entré
Full Throttle
Mar 24, 2026